Bioharmony Therapeutics
www.bioharmonytherapeutics.comAt Bioharmony Therapeutics, we are developing nontraditional antimicrobial therapeutics by exploiting millions of years of phage-bacteria evolution. Our focus is on targeting infectious diseases caused by multidrug-resistant (MDR) Gram-negative bacteria. Our primary therapeutic indication is for Acinetobacter baumannii skin and wound infections.
Read moreAt Bioharmony Therapeutics, we are developing nontraditional antimicrobial therapeutics by exploiting millions of years of phage-bacteria evolution. Our focus is on targeting infectious diseases caused by multidrug-resistant (MDR) Gram-negative bacteria. Our primary therapeutic indication is for Acinetobacter baumannii skin and wound infections.
Read moreCountry
State
New York
City (Headquarters)
New York City
Industry
Employees
1-10
Founded
2016
Social
Employees statistics
View all employeesPotential Decision Makers
Founder and Chief Executive Officer
Email ****** @****.comPhone (***) ****-****
Reach decision makers at Bioharmony Therapeutics
Free credits every month!
Bioharmony Therapeutics FAQ
New York City, United States
Biotechnology Research